Nova Patents
AT320711T

Exo-s-mecamylamine formulation and use in treatment

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

48 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
11253498United States of AmericaP

Members48

Family members, oldest first
DocumentOfficeKind
CA2393437A1CanadaA1
CA2393442A1CanadaA1
WO0035279A1World Intellectual Property Organization (WIPO)A1
WO0035280A1World Intellectual Property Organization (WIPO)A1
AU2368200AAustraliaA
AU2368600AAustraliaA
EP1139743A1European Patent Office (EPO)A1
EP1139744A1European Patent Office (EPO)A1
US2002016370A1United States of AmericaA1
US2002016371A1United States of AmericaA1
JP2002532392AJapanA
JP2002532393AJapanA
EP1139743A4European Patent Office (EPO)A4
EP1139744A4European Patent Office (EPO)A4
US2004044083A1United States of AmericaA1
US6734215B2United States of AmericaB2
EP1634498A2European Patent Office (EPO)A2
EP1139743B1European Patent Office (EPO)B1
EP1634498A3European Patent Office (EPO)A3
AT320711TThis recordAustriaT
ATE320711T1AustriaT1
DE69930552D1GermanyD1
PT1139743EPortugalE
DK1139743T3DenmarkT3
US7101916B2United States of AmericaB2
ES2260959T3SpainT3
DE69930552T2GermanyT2
US2006276551A1United States of AmericaA1
EP1634498B1European Patent Office (EPO)B1
AT406797TAustriaT
ATE406797T1AustriaT1
DE69939498D1GermanyD1
PT1634498EPortugalE
DK1634498T3DenmarkT3
ES2313187T3SpainT3
CA2393437CCanadaC
US2010286282A1United States of AmericaA1
US2011028565A1United States of AmericaA1
JP2011126909AJapanA
US8026283B2United States of AmericaB2
JP2014051528AJapanA
CY1108577T1CyprusT1
US2014194525A1United States of AmericaA1
JP2016065108AJapanA
US9593070B2United States of AmericaB2
US2017181983A1United States of AmericaA1
US2018250244A1United States of AmericaA1
US10188613B2United States of AmericaB2